Growth

Cause Marketing: It Is About Changing Behaviour

Cause marketing needs to progress. For the past decade we have heard that consumers are more willing to buy brands that support good causes. In fact, people are even prepared to switch brands and to pay a premium if the cause and brand resonate. This preference now extends to working for and investing in companies that do right.

Syntegrity
read more
How to Quickly Solve Complex Business Challenges

The last two hundred years saw economies and businesses grow from small and local into global and interconnected.The challenges those organizations faced along the way were predominantly “complicated” ones, mostly solved through research, analysis, and subject matter expertise. And, once solved, the solutions were repeatable.

Syntegrity
read more
How a Scientific Formula Can Positively Impact Business Outcomes

n(n-1) // In 1905, Albert Einstein introduced the world to e=mc2. It was a watershed moment. This devastatingly simple equation unlocked answers to the universe’s complexities, allowing us to do incredible things. n(n-1) is, similarly, simple and yet powerful: It is the key to quickly unlocking the answers to our largest and most complex challenges within all industries—creative, business, public, or non-profit.

Syntegrity
read more
Blockchain & The Internet at Scale

In certain circles, blockchain is touted as important an innovation as the creation of the internet. That kind of headline certainly attracts attention—and investors—but what is to be gleaned from that kind of statement?

Syntegrity
read more
About Syntegration

Syntegration is a proprietary, science-based methodology for quickly solving complex challenges, deepening relationships, and mobilizing large groups for execution. What follows is a description of the “classic” Syntegration format.

Syntegrity
read more
Complicated vs Complex Challenges in Pharma

The pace, scope, and variety of challenges we face as executives in Pharma are both invigorating and overwhelming.

Steve Figman
read more
In Pharma...Without Digital, It’s not a Strategy, and the 5 Reasons You May be Avoiding It

New and often asymmetrical competition is reshaping the market. Disruption is the new normal, the pace of innovation is accelerating, and data more important than ever.

Steve Figman
read more

join those in the know

Subscribe for all our latest insights on complexity.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form